AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2017
Apr 3, 2017
29828_dirs_2017-04-03_fc5e5dae-1cc7-47f2-93bd-0c0ff8355ed8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-03-30
Reporting Person: Alton Gregg H (EVP Comm&Acs ALA, Corp&Med Aff)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-30 | Common Stock | S | 5000 | $67.4784 | Disposed | 117988 | Direct |
Footnotes
F1: Sale prices reported for the transactions reported here range from $67.20 to $67.77. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
More from GILEAD SCIENCES, INC.
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30